Cargando…

Small Split Doses of CD34(+) Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy

Cumulative myelosuppression is the main limiting factor for administration of repeated cycles of chemotherapy. We present a case series of five pediatric patients with high-risk solid malignancies who received small split peripheral blood stem cells (PBSC) doses of less than 1 × 10(6)/kg CD34(+) cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yankelevich, Maxim, Savasan, Sureyya, Dolgopolov, Igor, Chu, Roland, Mentkevich, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702414/ https://www.ncbi.nlm.nih.gov/pubmed/29259833 http://dx.doi.org/10.1155/2017/4184879

Ejemplares similares

Graft-versus-Leukemia Effect of Nonmyeloablative Stem Cell Transplantation
por: Imamura, Masahiro, et al.
Publicado: (2009)

Identification of Paroxysmal Nocturnal Hemoglobinuria-Type Bone Marrow Mast Cells
por: Savaşan, Süreyya, et al.
Publicado: (2023)

Short telomere length in autoimmune neutropenia of childhood: A mere coincidence or an association?
por: Gorsi, Hamza S., et al.
Publicado: (2023)

Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning
por: De Bock, Muriel, et al.
Publicado: (2013)

Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation
por: Kim, Nayoun, et al.
Publicado: (2015)

What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?
por: Diaconescu, Razvan, et al.
Publicado: (2005)

Maintaining osteoclastogenesis following allogeneic hematopoietic stem cell transplantation for osteopetrosis: evidence from in vitro testing
por: Savaşan, Süreyya, et al.
Publicado: (2022)

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
por: Munchel, Ashley, et al.
Publicado: (2011)

A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma
por: Yu, K., et al.
Publicado: (2018)

(GT)(n) Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
por: Køllgaard, Tania, et al.
Publicado: (2016)

Idiopathic Pneumonia Syndrome and Thrombotic Microangiopathy Following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation and Posttransplant Cyclophosphamide: A Case Report
por: Liu, Wei-Hsin, et al.
Publicado: (2015)

High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients
por: Jaklič, Alenka, et al.
Publicado: (2013)

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation
por: Long-Boyle, Janel R, et al.
Publicado: (2010)

Nonmyeloablative Allogeneic Stem-Cell Transplantation for Metastatic Renal Cell Cancer: A Review and Update
por: Erotocritou, P., et al.
Publicado: (2006)

Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning
por: Schwaiger, Elisabeth, et al.
Publicado: (2012)

Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
por: Toh, H C, et al.
Publicado: (2011)

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
por: van der Velden, Walter J. F. M., et al.
Publicado: (2021)

Extension of Maximal Lifespan and High Bone Marrow Chimerism After Nonmyeloablative Syngeneic Transplantation of Bone Marrow From Young to Old Mice
por: Kovina, Marina V., et al.
Publicado: (2019)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer
por: Banna, G L, et al.
Publicado: (2006)

Expression of CD34 and CD31 in Central and Peripheral Giant Cell Granulomas
por: Sadri, Donia, et al.
Publicado: (2019)

Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
por: Walter, Roland B., et al.
Publicado: (2014)

The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice
por: Xian, Yexing, et al.
Publicado: (2020)

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
por: Kanda, Junya, et al.
Publicado: (2011)

Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease
por: Paplham, Pamela, et al.
Publicado: (2014)

Autologous nonmyeloablative hematopoietic stem cell transplantion in newly diagnosed childhood type 1 diabetes mellitus: the first year report
por: Luo, Feihong, et al.
Publicado: (2013)

Evolution of Graves’ Disease during Immune Reconstitution following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in a Boy Carrying Germline SAMD9L and FLT3 Variants
por: Ip, Peng Peng, et al.
Publicado: (2022)

Allogeneic bone marrow transplantation can suppress established and otherwise chronic collagen-induced arthritis after a nonmyeloablative conditioning regimen employing anti-CD40 ligand monoclonal antibody
por: Flierman, R, et al.
Publicado: (2004)

CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer
por: Lin, Yun, et al.
Publicado: (2021)

Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
por: Veltri, Lauren, et al.
Publicado: (2013)

The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron.
por: Aapro, M. S., et al.
Publicado: (1994)

Elevation of Peripheral Blood CD34+ and Platelet Levels After Exercise With Cooling and Compression
por: Callanan, Mark C., et al.
Publicado: (2021)

Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy
por: Penaforte-Saboia, Jaquellyne G., et al.
Publicado: (2017)

Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure
por: Hümmer, Christiane, et al.
Publicado: (2016)

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.
por: Chabannon, C., et al.
Publicado: (1998)

Expression of CD34 and CD68 in peripheral giant cell granuloma and central giant cell granuloma: An immunohistochemical analysis
por: VK, Varsha, et al.
Publicado: (2014)

Correlation between peripheral blood neutrophil-lymphocyte ratio and CD34 expression in prostate cancer
por: Wang, Yiyang, et al.
Publicado: (2020)

Evaluation of expanded peripheral blood derived CD34+ cells for the treatment of moderate knee osteoarthritis
por: Vignon, Christine, et al.
Publicado: (2023)

The Chemokine SDF-1 Is a Chemoattractant for Human CD34(+) Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34(+) Progenitors to Peripheral Blood
por: Aiuti, A., et al.
Publicado: (1997)

Smoking and Diabetes Attenuate Number of CD34(+) Haematopoietic Stem Cells in Peripheral Blood of Patients with Advanced Peripheral Artery Disease
por: Sernek, Barbara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0nmmmu3lj7ek5he15gmvadbj54